These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29157949)

  • 41. Analysis of baseline factors associated with reduction in chest pain in patients with angina pectoris treated by enhanced external counterpulsation.
    Lawson WE; Kennard ED; Hui JC; Holubkov R; Kelsey SF;
    Am J Cardiol; 2003 Aug; 92(4):439-43. PubMed ID: 12914875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.
    Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R
    Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals.
    Sajja V; Dod H; Beto R; Jain AC; Hobbs GR; Finkel MS
    W V Med J; 2007; 103(3):10-2. PubMed ID: 17849668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
    Storey KM; Wang J; Garberich RF; Bennett NM; Traverse JH; Arndt TL; Schmidt CW; Henry TD
    Am J Cardiol; 2020 Aug; 129():1-4. PubMed ID: 32540170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year.
    May O; Lynggaard V; Mortensen JC; Malczynski J
    Scand Cardiovasc J; 2015 Feb; 49(1):1-6. PubMed ID: 25471629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between N-terminal pro-brain natriuretic peptide levels and response to enhanced external counterpulsation in chronic angina pectoris.
    Sahlén A; Wu E; Rück A; Hagerman I; Förstedt G; Sylvén C; Berglund M; Jernberg T
    Coron Artery Dis; 2014 Jan; 25(1):45-51. PubMed ID: 24217402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).
    Soran O; Kennard ED; Kfoury AG; Kelsey SF;
    Am J Cardiol; 2006 Jan; 97(1):17-20. PubMed ID: 16377276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.
    Svorkdal N
    Semin Cardiothorac Vasc Anesth; 2004 Mar; 8(1):43-58. PubMed ID: 15372127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?
    Elder DH; Pauriah M; Lang CC; Shand J; Menown IB; Sin BD; Gupta S; Duckett SG; Foster W; Zachariah D; Kalra PR
    QJM; 2010 May; 103(5):305-10. PubMed ID: 20181676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]).
    Michaels AD; Linnemeier G; Soran O; Kelsey SF; Kennard ED
    Am J Cardiol; 2004 Feb; 93(4):461-4. PubMed ID: 14969624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies.
    Gallone G; Baldetti L; Tzanis G; Gramegna M; Latib A; Colombo A; Henry TD; Giannini F
    JACC Cardiovasc Interv; 2020 Jan; 13(1):1-19. PubMed ID: 31918927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging treatment options for refractory angina pectoris: ranolazine, shock wave treatment, and cell-based therapies.
    Gennari M; Gambini E; Bassetti B; Capogrossi M; Pompilio G
    Rev Cardiovasc Med; 2014; 15(1):31-7. PubMed ID: 24762464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EECP: a non-invasive therapy for refractory angina.
    Beaini Y; Morley C
    Practitioner; 2009 Feb; 253(1715):27-31. PubMed ID: 19326660
    [No Abstract]   [Full Text] [Related]  

  • 57. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pump away angina with EECP.
    Coughlin AM
    Nursing; 2004 Jan; 34(1):48-9. PubMed ID: 14722434
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris.
    Kumar A; Aronow WS; Vadnerkar A; Sidhu P; Mittal S; Kasliwal RR; Trehan N
    Am J Ther; 2009; 16(2):116-8. PubMed ID: 19300038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation.
    Pettersson T; Bondesson S; Cojocaru D; Ohlsson O; Wackenfors A; Edvinsson L
    BMC Cardiovasc Disord; 2006 Jun; 6():28. PubMed ID: 16776842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.